In The News Posted August 16, 2019 Share Posted August 16, 2019 SILVER SPRING, Md., Aug. 16, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.